4.5 Letter

Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia

Journal

OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-022-06618-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available